US4526714A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Conjugates of anticoagulant and protein
Assignee: Cordis Europa NV
•
Filing: 1982-12-13
•
Granted: 1985-07-02
•
Expires: 2002-12-13
Abstract
Abstract Conjugates are provided which are covalently bonded conjugates of an anticoagulant and protein that are prepared in the presence of a coupling agent that forms amide linkages between the anticoagulant and the protein. Such amide linking coupling agents exclude highly toxic coupling agents such as CNBr. These conjugates are useful for enhancing the blood compatibility of certain surfaces of a prosthetic device, a surgical apparatus, or an extra-corporeal medical device.
Inventors
- 👤 Jan Feijen
- 👤 Wilhelmus E. Hennink
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 04:27
CPC Classifications
C; C08; C08B; C08B37/00; C08B37/006; C08B37/0063; C08B37/0075; C08B37/0081; A; A61; A61L; A61L33/00; A61L33/0005; A61L33/0011
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
123 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with an anticoagulant material, wherein the process comprises adsorbing a protein-anticoagulant conjugate to said substrate, said substrate being a hydrophobic material or a hydrophilic material, said protein of the protein-anticoagulant conjugate being a water soluble protein that is non-crosslinked when adsorbed onto said substrate, and said protein-anticoagulant conjugate is prepared according to a process that includes coupling said anticoagulant to said water soluble, non-crosslinked protein within an aqueous medium and in the presence of a coupling agent and providing an anticoagulant-protein conjugate by using a coupling agent that is an amide bond forming agent to form an amide linkage between said anticoagulant and said protein.
Claim 2
Dependent Claim
123 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with an anticoagulant material, wherein the process comprises adsorbing a protein-anticoagulant conjugate to said substrate, said substrate being a hydrophobic material or a hydrophilic material, said protein of the protein-anticoagulant conjugate being a water soluble protein that is non-crosslinked when adsorbed onto said substrate, and said protein-anticoagulant conjugate is prepared according to a process that includes coupling said anticoagulant to said water soluble, non-crosslinked protein within an aqueous medium and in the presence of a coupling agent and providing an anticoagulant-protein conjugate by using a coupling agent that is an amide bond forming agent to form an amide linkage between said anticoagulant and said protein.
Claim 3
Dependent Claim
16 words
The process according to claim 1, wherein the process further includes intermolecular crosslinking of the protein.
Claim 4
Dependent Claim
13 words
The process according to claim 1, wherein said substrate is a hydrophobic material.
Claim 5
Dependent Claim
29 words
The process according to claim 1, wherein said anticoagulant is a heparinous material, said conjugate is a water soluble human protein-heparin conjugate, and said coupling agent is 1-ethyl-3-dimethylaminopropyl carbodiimide.
Claim 6
Dependent Claim
16 words
The process according to claim 4, wherein the process further includes intermolecular crosslinking of the protein.
Claim 7
Dependent Claim
13 words
The process according to claim 4, wherein said substrate is a hydrophobic material.
Claim 8
Dependent Claim
112 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with an anticoagulant material, wherein the process comprises chemically attaching a protein-anticoagulant conjugate having been prepared according to a process that includes selecting a water soluble human protein as said protein, coupling said anticoagulant to said protein within an aqueous medium and in the presence of a coupling agent and providing an anticoagulant-protein conjugate by using a coupling agent that is an amide bond forming agent to form an amide linkage between said anticoagulant and said protein, and the protein of said protein-anticoagulant conjugate is non-crosslinked and soluble when chemically attached to said substrate.
Claim 9
Dependent Claim
112 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with an anticoagulant material, wherein the process comprises chemically attaching a protein-anticoagulant conjugate having been prepared according to a process that includes selecting a water soluble human protein as said protein, coupling said anticoagulant to said protein within an aqueous medium and in the presence of a coupling agent and providing an anticoagulant-protein conjugate by using a coupling agent that is an amide bond forming agent to form an amide linkage between said anticoagulant and said protein, and the protein of said protein-anticoagulant conjugate is non-crosslinked and soluble when chemically attached to said substrate.
Claim 10
Dependent Claim
16 words
The process according to claim 7, wherein the process further includes intermolecular crosslinking of the protein.
Claim 11
Dependent Claim
26 words
The process according to claim 7, wherein said anticoagulant is a heparinous material, said conjugate is a protein-heparin conjugate, and said coupling agent is 1-ethyl-3-dimethylaminopropyl carbodiimide.
Claim 12
Dependent Claim
16 words
The process according to claim 9, wherein the process further includes intermolecular crosslinking of the protein.
Claim 13
Dependent Claim
85 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with anticoagulant material, wherein the process comprises coating the substrate with a protein component, said protein component being a non-crosslinked protein, wherein said protein component is a water soluble human protein that is coupled with anticoagulant by a procedure utilizing an amide bond forming agent as a coupling agent, said procedure being such that the coupled protein and anticoagulant is substantially non-crosslinked when coated onto the substrate.
Claim 14
Dependent Claim
85 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with anticoagulant material, wherein the process comprises coating the substrate with a protein component, said protein component being a non-crosslinked protein, wherein said protein component is a water soluble human protein that is coupled with anticoagulant by a procedure utilizing an amide bond forming agent as a coupling agent, said procedure being such that the coupled protein and anticoagulant is substantially non-crosslinked when coated onto the substrate.
Claim 15
Dependent Claim
19 words
The process according to claim 11, wherein said protein component is albumin and the anticoagulant is a heparinous material.
Claim 16
Dependent Claim
31 words
The process according to claim 11, wherein said anticoagulant is heparinous material, and wherein said protein component is coupled with heparin by a procedure utilizing 1-ethyl-3-dimethylaminopropyl carbodiimide as the coupling agent.
Claim 17
Dependent Claim
86 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with anticoagulant material, wherein the process comprises covalently linking a protein component to a substrate, said protein component being a non-crosslinked protein, wherein said protein component is a water soluble human protein that is coupled with anticoagulant by a procedure utilizing an amide bond forming agent as a coupling reagent, said procedure being such that the coupled protein and anticoagulant is substantially non-crosslinked when coated onto the substrate.
Claim 18
Dependent Claim
86 words
A process for the improvement of compatibility between blood and a substrate, the process including coating the substrate with anticoagulant material, wherein the process comprises covalently linking a protein component to a substrate, said protein component being a non-crosslinked protein, wherein said protein component is a water soluble human protein that is coupled with anticoagulant by a procedure utilizing an amide bond forming agent as a coupling reagent, said procedure being such that the coupled protein and anticoagulant is substantially non-crosslinked when coated onto the substrate.
Claim 19
Dependent Claim
19 words
The process according to claim 13, wherein said protein component is albumin and the anticoagulant is a heparinous material.
Claim 20
Dependent Claim
32 words
The process according to claim 13, wherein said anticoagulant is a heparinous material, and wherein said protein component is coupled with heparin by a procedure utilizing 1-ethyl-3-dimethylaminopropyl carbodiimide as the coupling agent.
References Cited (Backward Citations)
US3099600A
Cited
US4003792A
Cited
US4001200A
Cited
FR2318189A1
Cited
GB1515963A
Cited
DE2720544A1
Cited
US4082507A
Cited
US4342739A
Cited
US4329383A
Cited
US4326532A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1988-07-01 | 1988-12-31 | 1989-07-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1992-07-01 | 1992-12-31 | 1993-07-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1996-07-01 | 1996-12-31 | 1997-07-02 | $7700.00 | Window Closed / Lapsed |